Entity

Prous Institute for Biomedical Research

Biotechnology - Therapeutics and Diagnostics

Associated Company

 

Prous Institute for Biomedical Research is a family-owned group with over 50 years of experience in the field of biomedical research and clinical practice, committed to supporting the discovery of novel therapeutic and diagnostic approaches.

 

It was started as a spin-off of Prous Science (acquired by Thomson Reuters, now Clarivate Analytics, in 2007) under the guidance of its founder, Dr. Josep R. Prous Cochs, for the purpose of discovering new medicinal products by means of developing expert computational systems.

 

The applied research programs derived from these methodologies have led to new experimental drugs in different areas such as central nervous system diseases, cancer or metabolic diseases with multiple international patents.

 

In parallel, Prous Institute has evolved to expand its mission beyond its own developments by partnering and investing in transformative science initiatives.